Polar Capital Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6M | Sell |
1,002,340
-360,000
| -26% | -$11.3M | 0.17% | 113 |
|
|
2025
Q1 | $44.6M | Sell |
1,362,340
-325,590
| -19% | -$10.7M | 0.27% | 104 |
|
|
2024
Q4 | $61M | Sell |
1,687,930
-250,000
| -13% | -$9.04M | 0.34% | 75 |
|
|
2024
Q3 | $60.4M | Sell |
1,937,930
-2,580
| -0.1% | -$80.4K | 0.29% | 75 |
|
|
2024
Q2 | $51.9M | Hold |
1,940,510
| – | – | 0.31% | 82 |
|
|
2024
Q1 | $66.2M | Buy |
1,940,510
+1,145
| +0.1% | +$39.1K | 0.35% | 71 |
|
|
2023
Q4 | $56.1M | Buy |
1,939,365
+284,895
| +17% | +$8.24M | 0.34% | 81 |
|
|
2023
Q3 | $45.6M | Buy |
1,654,470
+150,000
| +10% | +$4.14M | 0.34% | 80 |
|
|
2023
Q2 | $45.2M | Buy |
1,504,470
+117,055
| +8% | +$3.52M | 0.23% | 88 |
|
|
2023
Q1 | $50.3M | Buy |
1,387,415
+368,295
| +36% | +$13.3M | 0.33% | 83 |
|
|
2022
Q4 | $36.4M | Buy |
1,019,120
+225,000
| +28% | +$8.03M | 0.29% | 105 |
|
|
2022
Q3 | $26.9K | Hold |
794,120
| – | – | 0.17% | 116 |
|
|
2022
Q2 | $23K | Sell |
794,120
-83,825
| -10% | -$2.42K | 0.13% | 131 |
|
|
2022
Q1 | $28.4K | Buy |
877,945
+250,000
| +40% | +$8.08K | 0.13% | 135 |
|
|
2021
Q4 | $18.3K | Buy |
+627,945
| New | +$18.3K | 0.07% | 174 |
|